Hypertrophic obstructive cardiomyopathy: review of surgical treatment

Jonathan Price, Nicholas Clarke, Aslan Turer, Eduard Quintana, Carlos Mestres, Lynn Huffman, Matthias Peltz, Michael Wait, W. Steves Ring, Michael Jessen, Pietro Bajona

Research output: Contribution to journalReview article

Abstract

Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. When it causes left ventricular outflow tract obstruction, treatment is guided to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation are proven safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and lasting reduction of left ventricular outflow tract obstruction.

Original languageEnglish (US)
Pages (from-to)594-607
Number of pages14
JournalAsian Cardiovascular and Thoracic Annals
Volume25
Issue number9
DOIs
StatePublished - Nov 1 2017

Fingerprint

Ventricular Outflow Obstruction
Hypertrophic Cardiomyopathy
Sudden Cardiac Death
Heart Diseases
Myocardium
Therapeutics
Population

Keywords

  • Ablation techniques
  • Cardiomyopathy
  • Heart septum
  • hypertrophic
  • left
  • Mitral valve
  • Ventricular function
  • Ventricular outflow obstruction

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Hypertrophic obstructive cardiomyopathy : review of surgical treatment. / Price, Jonathan; Clarke, Nicholas; Turer, Aslan; Quintana, Eduard; Mestres, Carlos; Huffman, Lynn; Peltz, Matthias; Wait, Michael; Ring, W. Steves; Jessen, Michael; Bajona, Pietro.

In: Asian Cardiovascular and Thoracic Annals, Vol. 25, No. 9, 01.11.2017, p. 594-607.

Research output: Contribution to journalReview article

@article{e89814055b81496098c6be9c0e1363ca,
title = "Hypertrophic obstructive cardiomyopathy: review of surgical treatment",
abstract = "Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. When it causes left ventricular outflow tract obstruction, treatment is guided to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation are proven safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and lasting reduction of left ventricular outflow tract obstruction.",
keywords = "Ablation techniques, Cardiomyopathy, Heart septum, hypertrophic, left, Mitral valve, Ventricular function, Ventricular outflow obstruction",
author = "Jonathan Price and Nicholas Clarke and Aslan Turer and Eduard Quintana and Carlos Mestres and Lynn Huffman and Matthias Peltz and Michael Wait and Ring, {W. Steves} and Michael Jessen and Pietro Bajona",
year = "2017",
month = "11",
day = "1",
doi = "10.1177/0218492317733111",
language = "English (US)",
volume = "25",
pages = "594--607",
journal = "Asian Cardiovascular and Thoracic Annals",
issn = "0218-4923",
publisher = "SAGE Publications Inc.",
number = "9",

}

TY - JOUR

T1 - Hypertrophic obstructive cardiomyopathy

T2 - review of surgical treatment

AU - Price, Jonathan

AU - Clarke, Nicholas

AU - Turer, Aslan

AU - Quintana, Eduard

AU - Mestres, Carlos

AU - Huffman, Lynn

AU - Peltz, Matthias

AU - Wait, Michael

AU - Ring, W. Steves

AU - Jessen, Michael

AU - Bajona, Pietro

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. When it causes left ventricular outflow tract obstruction, treatment is guided to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation are proven safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and lasting reduction of left ventricular outflow tract obstruction.

AB - Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. When it causes left ventricular outflow tract obstruction, treatment is guided to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation are proven safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and lasting reduction of left ventricular outflow tract obstruction.

KW - Ablation techniques

KW - Cardiomyopathy

KW - Heart septum

KW - hypertrophic

KW - left

KW - Mitral valve

KW - Ventricular function

KW - Ventricular outflow obstruction

UR - http://www.scopus.com/inward/record.url?scp=85038572258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038572258&partnerID=8YFLogxK

U2 - 10.1177/0218492317733111

DO - 10.1177/0218492317733111

M3 - Review article

C2 - 28901158

AN - SCOPUS:85038572258

VL - 25

SP - 594

EP - 607

JO - Asian Cardiovascular and Thoracic Annals

JF - Asian Cardiovascular and Thoracic Annals

SN - 0218-4923

IS - 9

ER -